Paper42007256
Biofabrication strategies for engineered constructs in cardiovascular tissue repair.
Yu J and 3 others. Regen Ther, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Biofabrication strategies for engineered constructs in cardiovascular tissue repair. Papers, record 42007256. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42007256
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References140
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22864415 | Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. | Nature | 2012 | https://conductscience.org/library/papers/22864415 | PubMed |
| 2 | 19664819 | Scaffold-free vascular tissue engineering using bioprinting. | Biomaterials | 2009 | https://conductscience.org/library/papers/19664819 | PubMed |
| 3 | 38051475 | Clopidogrel-loaded vascular grafts prepared using digital light processing 3D printing. | Drug Deliv Transl Res | 2024 | https://conductscience.org/library/papers/38051475 | PubMed |
| 4 | 36522661 | A review on cell damage, viability, and functionality during 3D bioprinting. | Mil Med Res | 2022 | https://conductscience.org/library/papers/36522661 | PubMed |
| 5 | 40473768 | Development of a two-layer 3D equine endometrial tissue model using genipin-crosslinked collagen scaffolds and 3D printing. | Sci Rep | 2025 | https://conductscience.org/library/papers/40473768 | PubMed |
| 6 | 40100190 | Regulatory advancements in Japan's conditional and time-limited approval scheme for regenerative medical products: the first guidance on the approval scheme and the second review for full approval of the first conditional and time-limited approved cellular product, HeartSheet. | Cytotherapy | 2025 | https://conductscience.org/library/papers/40100190 | PubMed |
| 7 | 15210060 | Autologous transplantation of bone marrow mononuclear cells improved heart function after myocardial infarction. | Acta Pharmacol Sin | 2004 | https://conductscience.org/library/papers/15210060 | PubMed |
| 8 | 26781342 | Decellularization of porcine skeletal muscle extracellular matrix for the formulation of a matrix hydrogel: a preliminary study. | J Cell Mol Med | 2016 | https://conductscience.org/library/papers/26781342 | PubMed |
| 9 | 40530043 | Highly printable and multifunctional cell-laden collagen-based bioinks for precise DLP bioprinting and rapid diabetic wound regeneration. | Mater Today Bio | 2025 | https://conductscience.org/library/papers/40530043 | PubMed |
| 10 | 35513020 | Human umbilical cord-derived stem cell sheets improve left ventricular function in rat models of ischemic heart failure. | Eur J Pharmacol | 2022 | https://conductscience.org/library/papers/35513020 | PubMed |
| 11 | 33006880 | 3D Bioprinting-Tunable Small-Diameter Blood Vessels with Biomimetic Biphasic Cell Layers. | ACS Appl Mater Interfaces | 2020 | https://conductscience.org/library/papers/33006880 | PubMed |
| 12 | 38494389 | MSCs-Derived Decellularised Matrix: Cellular Responses and Regenerative Dentistry. | Int Dent J | 2024 | https://conductscience.org/library/papers/38494389 | PubMed |
| 13 | 39961914 | Assessing the landscape of clinical and observational trials involving bioprinting: a scoping review. | 3D Print Med | 2025 | https://conductscience.org/library/papers/39961914 | PubMed |
| 14 | 29116998 | Mesenchymal Stem Cells From Bone Marrow, Adipose Tissue, and Lung Tissue Differentially Mitigate Lung and Distal Organ Damage in Experimental Acute Respiratory Distress Syndrome. | Crit Care Med | 2018 | https://conductscience.org/library/papers/29116998 | PubMed |
| 15 | 24876342 | Bioreactor for modulation of cardiac microtissue phenotype by combined static stretch and electrical stimulation. | Biofabrication | 2014 | https://conductscience.org/library/papers/24876342 | PubMed |
| 16 | 40012508 | Development of a VEGF-activated scaffold with enhanced angiogenic and neurogenic properties for chronic wound healing applications. | Biomater Sci | 2025 | https://conductscience.org/library/papers/40012508 | PubMed |
| 17 | 27903111 | Electrical Stimulation Enhances Cardiac Differentiation of Human Induced Pluripotent Stem Cells for Myocardial Infarction Therapy. | Antioxid Redox Signal | 2018 | https://conductscience.org/library/papers/27903111 | PubMed |
| 18 | 20811099 | Biofabrication: a 21st century manufacturing paradigm. | Biofabrication | 2009 | https://conductscience.org/library/papers/20811099 | PubMed |
| 19 | 16423569 | Longer preservation of cardiac performance by sheet-shaped myoblast implantation in dilated cardiomyopathic hamsters. | Cardiovasc Res | 2006 | https://conductscience.org/library/papers/16423569 | PubMed |
| 20 | 27658612 | Bioink properties before, during and after 3D bioprinting. | Biofabrication | 2016 | https://conductscience.org/library/papers/27658612 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42007256
GET https://conductscience.org/api/papers/v1/42007256/references?page=2